Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets
PJ Bugelski, PL Martin - British Journal of Pharmacology, 2012 - Wiley Online Library
Monoclonal antibodies (mAbs) and fusion proteins directed towards cell surface targets
make an important contribution to the treatment of disease. The purpose of this review was …
make an important contribution to the treatment of disease. The purpose of this review was …
Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets
PJ Bugelski, PL Martin - British Journal of Pharmacology, 2012 - cir.nii.ac.jp
抄録< jats: p> Monoclonal antibodies (mAbs) and fusion proteins directed towards cell
surface targets make an important contribution to the treatment of disease. The purpose of …
surface targets make an important contribution to the treatment of disease. The purpose of …
Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets
PJ Bugelski, PL Martin - British journal of pharmacology, 2012 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) and fusion proteins directed towards cell surface targets
make an important contribution to the treatment of disease. The purpose of this review was …
make an important contribution to the treatment of disease. The purpose of this review was …
Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.
PJ Bugelski, PL Martin - British Journal of Pharmacology, 2012 - europepmc.org
Monoclonal antibodies (mAbs) and fusion proteins directed towards cell surface targets
make an important contribution to the treatment of disease. The purpose of this review was …
make an important contribution to the treatment of disease. The purpose of this review was …
[HTML][HTML] Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets
PJ Bugelski, PL Martin - British Journal of Pharmacology, 2012 - ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) and fusion proteins directed towards cell surface targets
make an important contribution to the treatment of disease. The purpose of this review was …
make an important contribution to the treatment of disease. The purpose of this review was …
[引用][C] Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets
PJ BUGELSKI, PL MARTIN - British journal of pharmacology, 2012 - pascal-francis.inist.fr
Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal
antibodies and fusion proteins: cell surface targets CNRS Inist Pascal-Francis CNRS Pascal and …
antibodies and fusion proteins: cell surface targets CNRS Inist Pascal-Francis CNRS Pascal and …
Concordance of preclinical and clinical pharmacology and toxicology of therapeutic monoclonal antibodies and fusion proteins: cell surface targets.
PJ Bugelski, PL Martin - British Journal of Pharmacology, 2012 - europepmc.org
Monoclonal antibodies (mAbs) and fusion proteins directed towards cell surface targets
make an important contribution to the treatment of disease. The purpose of this review was …
make an important contribution to the treatment of disease. The purpose of this review was …